DripDok was the first in Indonesia to perform NAD+ and elite peptide infusions 2020 after over 2 years of clinical trials (2018-2019).
Monitored by a compassionate team of highly trained, knowledgeable medical clinicians. We are an Evidence-Based Center of Excellence established in recent NDA+, peptide, and NMDA antagonists and committed to advancing such research by utilizing patient improvements to measure results to ultimately improve patient outcomes.
Meet The Team Here
Be extremely careful on what you infuse into your body. NAD+ infusions must be very carefully prepared and stored. Most don’t know the proper membrane, charge or endotoxin acceptability. They simply copy what they see.
DripDok was developed and founded by a Harvard, MIT and Purdue graduate who holds a Doctorate in physical medicine.
Besides having compounds that are of the highest grade and purity. We track, monitor and measure your progress.
Your health data drives the process.
We also know that infusion grade NAD+ and peptides are incredible rare and expensive. These chemicals require extensive testing, high purification,specific storage and transport in order to be effective and safe.
Moreover, we found that our competitors had NAD+ that was non-biologically active, exceeded endotoxin levels safe for infusion and were stored and transported improperly.
If you are going to have a substance infused into your body, best to have absolute peace of mind.
That’s the DripDok difference.